Journey Medical Reports $19.0 Million Revenue and Positive Adjusted EBITDA

Journey Medical reported third-quarter 2026 revenue of $19.0 million, up 8% year over year, and a GAAP net loss of $1.3 million. The company posted positive adjusted EBITDA of $3.5 million, or $0.12 per diluted share. Emrosi revenue increased 84% from the prior-year quarter.Financial HighlightsBusi…